Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1530/ERC-20-0229 http://scihub22266oqcxt.onion/10.1530/ERC-20-0229 32744242!ä!32744242 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32744242.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Endocr+Relat+Cancer 2020 ; 27 (9): R357-R374 Nephropedia Template TP {{tp|p=32744242|t=2020. Management changes for patients with endocrine-related cancers in the COVID-19 pandemic |pdf=|usr=}}{{32744242}} gab.com Text Management changes for patients with endocrine-related cancers in the COVID-19 pandemic JO: Endocr Relat Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32744242 #FOAvip Substantial management changes in endocrine-related malignancies have been required as a response to the COVID-19 pandemic, including a draconian reduction in the screening of asymptomatic subjects, delay in planned surgery and radiotherapy for primary tumors deemed to be indolent, and dose reductions and/or delays in initiation of some systemic therapies. An added key factor has been a patient-initiated delay in the presentation because of the fear of viral infection. Patterns of clinical consultation have changed, including a greater level of virtual visits, physical spacing, masking, staffing changes to ensure a COVID-free population and significant changes in patterns of family involvement. While this has occurred to improve safety from COVID-19 infection, the implications for cancer outcomes have not yet been defined. Based on prior epidemics and financial recessions, it is likely that delayed presentation and treatment of high-grade malignancy will be associated with worse cancer outcomes. Cancer patients are also at increased risk from COVID-19 infection compared to the general population. Pandemic management strategies for patients with tumors of breast, prostate, thyroid, parathyroid and adrenal gland are reviewed. Twit Text FOAVip Management changes for patients with endocrine-related cancers in the COVID-19 pandemic ????Endocr Relat Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32744242 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32744242 #FOAvip English Wikipedia <ref>{{Cite pmid|32744242}}</ref> Management changes for patients with endocrine-related cancers in the COVID-19 pandemic #MMPMID32744242 Raghavan D; Tan AR; Story ES; Burgess EF; Musselwhite L; Kim ES; Clark PE Endocr Relat Cancer 2020[Sep]; 27 (9): R357-R374 PMID32744242show ga Substantial management changes in endocrine-related malignancies have been required as a response to the COVID-19 pandemic, including a draconian reduction in the screening of asymptomatic subjects, delay in planned surgery and radiotherapy for primary tumors deemed to be indolent, and dose reductions and/or delays in initiation of some systemic therapies. An added key factor has been a patient-initiated delay in the presentation because of the fear of viral infection. Patterns of clinical consultation have changed, including a greater level of virtual visits, physical spacing, masking, staffing changes to ensure a COVID-free population and significant changes in patterns of family involvement. While this has occurred to improve safety from COVID-19 infection, the implications for cancer outcomes have not yet been defined. Based on prior epidemics and financial recessions, it is likely that delayed presentation and treatment of high-grade malignancy will be associated with worse cancer outcomes. Cancer patients are also at increased risk from COVID-19 infection compared to the general population. Pandemic management strategies for patients with tumors of breast, prostate, thyroid, parathyroid and adrenal gland are reviewed. |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/epidemiology/*prevention & control/transmission/virology[MESH] |Disease Management[MESH] |Endocrine Gland Neoplasms/*therapy/virology[MESH] |Female[MESH] |Humans[MESH] |Infection Control/*organization & administration[MESH] |Pandemics/*prevention & control[MESH] |Patient Care/*standards[MESH] |Pneumonia, Viral/epidemiology/*prevention & control/transmission/virology[MESH] |Practice Guidelines as Topic/*standards[MESH]Management changes for patients with endocrine-related cancers in the (epmc).pdf DeepDyve Pubget Overpricing